About Richmond Pharmacology
An integrated solution to your Early Phase requirements
“Our goal is to deliver full service Early Phase clinical solutions swiftly, efficiently, and to the highest clinical standard. Our integrated set-up is designed to manage your Early Phase study within the controlled environment of Phase I. We compliment this through our out-patient facilities offering flexibility through the Phases in clinical trials.
“Richmond Pharmacology is the UK's only Early Phase Clinical Research Organisation (CRO) to conduct trials from within 2 acute NHS Teaching Hospitals. We are based within St George's Hospital, St George's University London, and Mayday University Hospital. Through our unique NHS Trust surroundings, we provide innovative Early Phase clinical and SMO (Site Management Organisation) solutions to 7 of the world's top 10 pharmaceutical companies.
“Finally, our on-site access to consultants across an unrivalled range of therapeutic areas ensures your study is designed and delivered to the highest clinical standard, from Protocol to Report.”
Dr Jörg Täubel, Managing Director, Richmond Pharmacology.
